NCT02364167

Brief Summary

The study entitled "Acupuncture vs. placebo acupuncture and vs. standard therapy for pain control after elective caesarian section - a randomized controlled trial" aims to investigate whether acupuncture with indwelling fixed needles reduces pain and analgesic requirement as compared to placebo and standard therapy in patients after after elective caesarian section (CS) in the period from January 2015 to May 2016. For that purpose 180 adult patients scheduled to elective elective CS in spinal anesthesia will be recruited according to eligibility criteria. 120 patients will be randomized either to verum or placebo acupuncture, 60 patients will be included in non-randomized "standard therapy" arm. The outcome measures are: postoperative analgesic requirement, pain intensity, incidence of side effects and physiological parameters.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for phase_2 postoperative-pain

Timeline
Completed

Started Jan 2015

Longer than P75 for phase_2 postoperative-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 13, 2015

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

February 9, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 16, 2015

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 27, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 27, 2018

Completed
Last Updated

January 11, 2021

Status Verified

January 1, 2021

Enrollment Period

3.5 years

First QC Date

February 9, 2015

Last Update Submit

January 8, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain intensity as measured by Numeric Rating Scale 1-10

    4:00 P.M. on the 1st postoperative day

Secondary Outcomes (2)

  • Total requirement of postoperative analgesics

    4:00 P.M. on the 2nd postoperative day

  • Incidence of complications and adverse effects

    4:00 P.M. on the 2nd postoperative day

Study Arms (3)

Verum acupuncture

EXPERIMENTAL

Each patient will receive 16 permanent indwelling acupuncture needles, embedded in adhesive tape, bilaterally in addition to standard postoperative analgesia

Drug: Standard therapyDevice: Verum acupuncture

Placebo acupuncture

PLACEBO COMPARATOR

Each patient will receive 16 adhesive tapes mimicking the indwelling acupuncture needles bilaterally in addition to standard postoperative analgesia

Drug: Standard therapyOther: Placebo acupuncture

Standard therapy

ACTIVE COMPARATOR

Each patient will receive just standard postoperative analgesia

Drug: Standard therapy

Interventions

Standard therapy includes pharmacologic treatment of postoperative pain according to the standards of our University hospital

Also known as: Pharmacologic therapy of postoperative pain
Placebo acupunctureStandard therapyVerum acupuncture

Verum acupuncture will be performed using indwelling permanent acupuncture needles "New Pyonex" with 1,5 mm length, manufactured by Seirin Corp. Japan

Verum acupuncture

Placebo acupuncture will be performed using the placebo "New Pyonex" adhesive tapes, mimicking the needles, manufactured by Seirin Corp. Japan

Also known as: Placebo
Placebo acupuncture

Eligibility Criteria

Age19 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with an American Society of Anaesthesiologists physical status of I to III scheduled for elective caesarean section in spinal anaesthesia
  • Surgery time does not exceed 60 minutes
  • Patients without previous opioid and psychotropic medication
  • Patients ranged 19-45 years old
  • Patients who have given written informed consent

You may not qualify if:

  • Recidivist alcoholics
  • Local skin infection at the sites of acupuncture
  • Age \< 19 and \> 45 years
  • Switching to general anaesthesia in cases where spinal anaesthesia fails
  • Surgery time more than 60 minutes
  • Intraoperative complications (bleeding, required blood transfusion more than 6 units of packed cells, cardiovascular instability, required catecholamines except for short hypotension after induction of spinal anaesthesia )
  • Patients who consumed opioid medication at least 6 months before surgery
  • Patients who are unable to understand the consent form and fill in the study questionnaire
  • History of psychiatric disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ernst Moritz Arndt University

Greifswald, 17475, Germany

Location

Related Publications (3)

  • Usichenko TI. Acupuncture as part of multimodal analgesia after caesarean section. Acupunct Med. 2014 Jun;32(3):297-8. doi: 10.1136/acupmed-2014-010584. Epub 2014 May 7. No abstract available.

    PMID: 24809368BACKGROUND
  • Usichenko TI, Henkel BJ, Klausenitz C, Hesse T, Pierdant G, Cummings M, Hahnenkamp K. Effectiveness of Acupuncture for Pain Control After Cesarean Delivery: A Randomized Clinical Trial. JAMA Netw Open. 2022 Feb 1;5(2):e220517. doi: 10.1001/jamanetworkopen.2022.0517.

  • Zimpel SA, Torloni MR, Porfirio GJ, Flumignan RL, da Silva EM. Complementary and alternative therapies for post-caesarean pain. Cochrane Database Syst Rev. 2020 Sep 1;9(9):CD011216. doi: 10.1002/14651858.CD011216.pub2.

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Taras I Usichenko, MD, PhD

    University Medicine of Greifswald

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 9, 2015

First Posted

February 16, 2015

Study Start

January 13, 2015

Primary Completion

June 27, 2018

Study Completion

June 27, 2018

Last Updated

January 11, 2021

Record last verified: 2021-01

Locations